Baiyunshan Receives SSE Approval for Guangzhou Pharmaceutical Receivables ABS Listing

Stock News
03/16

Baiyushan PH (00874) announced that on March 13, 2026, the company received a no-objection letter from the Shanghai Stock Exchange (SSE) forwarded by Industrial Securities Asset Management Co., Ltd. The letter confirms that the asset-backed securities for the Xingzheng Yuanrong-Guangzhou Pharmaceutical Receivables Phases 5-9 Special Asset-Backed Plan meet the SSE's listing requirements, and the exchange has no objection to their listing and transfer. The asset-backed securities will be issued in multiple tranches, adopting a non-renewable issuance structure, with a total issuance amount not exceeding RMB 3 billion. The first tranche must be completed within 12 months from the date of the no-objection letter. The letter remains valid for 24 months from its issuance date.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10